Business & Finance
Pfizer's board approves USD0.34 dividend for Q4 2018
28 September 2018 -

The board of directors of Pfizer Inc (NYSE:PFE) declared on Thursday its dividend of USD0.34 on its common stock for the Q4 2018.

Shareholders of record at the close of business on 9 November 2018 will receive the dividend payment on 3 December 2018.

In addition, the cash dividend will be the company's 320th consecutive quarterly dividend.

According to the company, it is engaged in the discovery, development and manufacture of health care products, including medicines and vaccines as well as many of the world's best-known consumer health care products.